Atul J. Butte | |
---|---|
![]() | |
Alma mater | Brown University, MIT |
Known for | Translational biomedical informatics using large, publicly available data-sets; data-driven personalized-systems medicine; genomic nosology |
Awards | Young Investigator Award, Society for Pediatric Research (2010); Elected Fellow, American College of Medical Informatics (2009); New Investigator Award, American Medical Informatics Association (2008); Tomorrow's Principal Investigator, Genome Technology Magazine (2007); HHMI Physician-Scientist Early Career Award, Howard Hughes Medical Institute (2006–2011); National Academy of Medicine (IOM, 2015) [1] |
Scientific career | |
Fields | Bioinformatics, health informatics, endocrinology, personalized medicine, genomics, big data, datamining |
Institutions | UCSF |
Doctoral advisor | Isaac Kohane |
Doctoral students | Joel Dudley |
Atul J. Butte is a biomedical informatics researcher and biotechnology entrepreneur. He is currently the Priscilla Chan and Mark Zuckerberg Distinguished Professor at the University of California, San Francisco. Since April 2015, Butte has serves as inaugural director of UCSF's Bakar Computational Health Sciences Institute. [2]
Previously, Butte was Chief of the Division of Systems Medicine at Stanford University School of Medicine and Lucile Packard Children's Hospital where he held the position of an associate professor of pediatrics and (by courtesy) computer science and immunology & rheumatology. [3]
Butte attended Brown University, where he studied computer science as an undergrad. As a member of the school's Program in Liberal Medical Education he was guaranteed acceptance to Brown's Alpert Medical School, where he obtained his MD in 1995.
Butte completed a residency in pediatrics and a fellowship in pediatric endocrinology, both at Children's Hospital Boston. In 2004, he completed a Ph.D. from the Harvard–MIT Division of Health Sciences and Technology, supervised by Dr. Isaac Kohane. [4]
Butte has an h-index of over 85 and is recognized by Publons as a highly cited researcher. [5] [6] He has also founded two biotechnology companies (Personalis [7] and NuMedii [8] ) and wrote one of the first books on microarray analysis, Microarrays for an Integrative Genomics.
In April 2012, Butte delivered a TEDMED talk describing his lab's development of techniques using massive amount of publicly available biomedical research data to make new discoveries without running a wet-lab and actually outsourcing experiments using assaydepot.com. [9]
Butte lives with his wife, Gini Deshpande, a cancer biology and biotechnology entrepreneur, and daughter in Menlo Park, CA. [10] [11] As of 2018 [update] , Deshpande was the chief executive officer of NuMedii, an artificial intelligence technology company. [12]
In 2021, Butte was elected as a Fellow of the International Society for Computational Biology. [13]
The University of California, San Francisco (UCSF) is a public land-grant research university in San Francisco, California. It is part of the University of California system and is dedicated entirely to health science and life science. It conducts research and teaching in medical and biological sciences.
Joseph Lyman DeRisi is an American biochemist, specializing in molecular biology, parasitology, genomics, virology, and computational biology.
The Harvard–MIT Program in Health Sciences and Technology, or HST, is one of the oldest and largest biomedical engineering and physician-scientist training programs in the United States. It was founded in 1970 and is the longest-standing collaboration between Harvard University and the Massachusetts Institute of Technology (MIT). Within the program, graduate and medical students are registered with both MIT and Harvard and may work with faculty and affiliated faculty members from both communities. HST is a part of MIT's Institute for Medical Engineering and Science and forms the London Society at Harvard Medical School.
David J. Lipman is an American biologist who from 1989 to 2017 was the director of the National Center for Biotechnology Information (NCBI) at the National Institutes of Health. NCBI is the home of GenBank, the U.S. node of the International Sequence Database Consortium, and PubMed, one of the most heavily used sites in the world for the search and retrieval of biomedical information. Lipman is one of the original authors of the BLAST sequence alignment program, and a respected figure in bioinformatics. In 2017, he left NCBI and became Chief Science Officer at Impossible Foods.
Steven Lloyd Salzberg is an American computational biologist and computer scientist who is a Bloomberg Distinguished Professor of Biomedical Engineering, Computer Science, and Biostatistics at Johns Hopkins University, where he is also Director of the Center for Computational Biology.
Russ Biagio Altman is an American professor of bioengineering, genetics, medicine, and biomedical data science and past chairman of the bioengineering department at Stanford University.
Mark Borodovsky is a Regents' Professor at the Join Wallace H. Coulter Department of Biomedical Engineering of Georgia Institute of Technology and Emory University and Director of the Center for Bioinformatics and Computational Genomics at Georgia Tech. He has also been a Chair of the Department of Bioinformatics at the Moscow Institute of Physics and Technology in Moscow, Russia from 2012 to 2022.
Sue Desmond-Hellmann is an American oncologist and biotechnology leader who served as the Chief Executive Officer of the Bill & Melinda Gates Foundation from 2014–2020. She was previously Chancellor of the University of California, San Francisco (UCSF), the first woman to hold the position, and Arthur and Toni Rembe Rock Distinguished Professor, and before that president of product development at Genentech, where she played a role in the development of the first gene-targeted cancer drugs, Avastin and Herceptin.
Lawrence E. Hunter is a Professor and Director of the Center for Computational Pharmacology and of the Computational Bioscience Program at the University of Colorado School of Medicine and Professor of Computer Science at the University of Colorado Boulder. He is an internationally known scholar, focused on computational biology, knowledge-driven extraction of information from the primary biomedical literature, the semantic integration of knowledge resources in molecular biology, and the use of knowledge in the analysis of high-throughput data, as well as for his foundational work in computational biology, which led to the genesis of the major professional organization in the field and two international conferences.
Aviv Regev is a computational biologist and systems biologist and Executive Vice President and Head of Genentech Research and Early Development in Genentech/Roche. She is a core member at the Broad Institute of MIT and Harvard and professor at the Department of Biology of the Massachusetts Institute of Technology. Regev is a pioneer of single cell genomics and of computational and systems biology of gene regulatory circuits. She founded and leads the Human Cell Atlas project, together with Sarah Teichmann.
David A. Agard is a professor of biochemistry and biophysics at the University of California, San Francisco. He earned his B.S. in molecular biochemistry and biophysics from Yale University and his Ph.D. in biological chemistry from California Institute of Technology. His research is focused on understanding the basic principles of macromolecular structure and function. He is a scientific director of the Institute for Bioengineering, Biotechnology, and Quantitative Biomedical Research and has been a Howard Hughes Medical Institute (HHMI) investigator since 1986.
Translational bioinformatics (TBI) is a field that emerged in the 2010s to study health informatics, focused on the convergence of molecular bioinformatics, biostatistics, statistical genetics and clinical informatics. Its focus is on applying informatics methodology to the increasing amount of biomedical and genomic data to formulate knowledge and medical tools, which can be utilized by scientists, clinicians, and patients. Furthermore, it involves applying biomedical research to improve human health through the use of computer-based information system. TBI employs data mining and analyzing biomedical informatics in order to generate clinical knowledge for application. Clinical knowledge includes finding similarities in patient populations, interpreting biological information to suggest therapy treatments and predict health outcomes.
Dana Pe'er, Chair and Professor in Computational and Systems Biology Program at Sloan Kettering Institute is a researcher in computational systems biology. A Howard Hughes Medical Institute (HHMI) Investigator since 2021, she was previously a professor at Columbia Department of Biological Sciences. Pe'er's research focuses on understanding the organization, function and evolution of molecular networks, particularly how genetic variations alter the regulatory network and how these genetic variations can cause cancer.
Leor S. Weinberger is an American virologist and quantitative biologist. He is credited with discovering the HIV virus latency circuit, which provided the first experimental evidence that stochastic fluctuations ('noise') in gene expression are used for cell fate decisions. He has also pioneered the concept of therapeutic interfering particles, or “TIPs”, which are resistance-proof antivirals. His TED talk on this novel antiviral approach 20 years in the making has been called a "highlight" of TED and received a standing ovation from the live audience.
Euan Angus Ashley is a Scottish physician, scientist, author, and founder based at Stanford University in California where he is Associate Dean in the School of Medicine and holds the Roger and Joelle Burnell Chair of Genomics and Precision Health. He is known for helping establish the field of medical genomics.
Scientist.com is a network of public and private e-commerce marketplaces that connect buyers and sellers of scientific research services. The company was founded in 2007 by Kevin Lustig, Chris Petersen and Andrew Martin and launched its first public research marketplace in September 2008.
Núria López Bigas is a Spanish biologist and research professor with expertise in medical genetics, computational biology, and bioinformatics. She is an ICREA professor at Pompeu Fabra University and she also leads the Biomedical Genomics Research Group at the Institute for Research in Biomedicine in Barcelona, Spain. Her research is focused on developing computational approaches to investigate cancer genomes.
Eleazar Eskin is a computer scientist and geneticist, professor and Chair of the Department of Computational Medicine, and professor of computer science and human genetics at the University of California, Los Angeles. His research focuses on bioinformatics, genomics, and machine learning. A primary research focus is on developing statistical and computational techniques to probe the genetic basis of human disease.
Gustavo A. Stolovitzky is an Argentine-American computational systems biologist. He is an IBM Fellow and the Director of the Translational Systems Biology and Nano-Biotechnology Program at IBM Research. He serves as the program director of the Thomas J. Watson Research Center's Translational Systems Biology and Nanobiotechnology Program, as well as an Adjunct professor of Genetics and Genomic Sciences at the Icahn School of Medicine at Mount Sinai and an Adjunct Associate Professor of Biomedical Informatics at Columbia University. His research has been cited more than 20,000 times
Katherine Snowden Pollard is the Director of the Gladstone Institute of Data Science and Biotechnology and a professor at the University of California, San Francisco (UCSF). She is a Chan Zuckerberg Biohub Investigator. She was awarded Fellowship of the International Society for Computational Biology in 2020 and the American Institute for Medical and Biological Engineering in 2021 for outstanding contributions to computational biology and bioinformatics.